AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17803837 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care (case manager-coordinated medication support and brief psychological treatment, enhanced specialist and GP communication)
Number of subjects: 114
Study 17803837 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care
Number of subjects: 114
Study 17803837 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 114
Study 15601269 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of ephedrine
Number of subjects: 60
Study 15601269 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of mephentermine
Number of subjects: 60
Study 12227391 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin 1 g/L intraperitoneally as loading dose, repeated on day 5 or day 8 for 2 weeks.
Number of subjects: 30
Study 12227391 — intervention group
Group type: COMPARATOR
Intervention: Cefazolin 1 g in the first PD bag and continued with 125 mg/L every exchange for 2 or 3 weeks, depending on culture results.
Number of subjects: 30
Study 12227391 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin
Number of subjects: 30
Study 12227391 — intervention group
Group type: COMPARATOR
Intervention: Cefazolin
Number of subjects: 30
Study 9708650 — intervention group
Group type: EXPERIMENTAL
Intervention: tissue plasminogen activator (t‐PA) therapy within 2 hours of acute symptom onset
Number of subjects: 71253
Study 9708650 — intervention group
Group type: COMPARATOR
Intervention: tissue plasminogen activator (t‐PA) therapy after 2 hours
Number of subjects: 71253
Study 9708650 — intervention group
Group type: EXPERIMENTAL
Intervention: tissue plasminogen activator (t‐PA) therapy
Number of subjects: 71253
Study 8751015 — intervention group
Group type: EXPERIMENTAL
Intervention: lisinopril
Number of subjects: 12
Study 8751015 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study 2095291 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (5 mg), administered 2 hours after reading the text
Number of subjects: 88
Study 2095291 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg), administered before reading the text
Number of subjects: 88
Study 2095291 — intervention group
Group type: COMPARATOR
Intervention: Placebo, administered before reading the text
Number of subjects: 88
Study 2095291 — intervention group
Group type: COMPARATOR
Intervention: Placebo, administered 2 hours after reading the text
Number of subjects: 88
Study 668776 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated charcoal 50 g suspended in water
Number of subjects: 6
Study 31742823 — intervention group
Group type: EXPERIMENTAL
Intervention: EMC2 intervention
Number of subjects: 652
Study 31742823 — intervention group
Group type: EXPERIMENTAL
Intervention: EMC2 + SMS intervention
Number of subjects: 652
Study 31742823 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 652
Study 28219430 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital health system (tablet computer and pulse oximeter)
Number of subjects: 110
Study 26539764 — intervention group
Group type: EXPERIMENTAL
Intervention: COSS (new organizational return-to-work intervention)
Number of subjects: 0
Study 26539764 — intervention group
Group type: COMPARATOR
Intervention: Common practice (control)
Number of subjects: 0
Study 23089685 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visits by nurses about 48‐72 hours after discharge
Number of subjects: 71
Study 23089685 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 71
Study 21832184 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation (TMS) applied during saccadic eye movements
Number of subjects: 0
Study 21832184 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation (TMS) applied during coordinated movements of both eyes and lids
Number of subjects: 0
Study 21832184 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation (TMS) applied repeatedly
Number of subjects: 0
Study 21832184 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation (TMS) during pro-saccades and anti-saccades
Number of subjects: 0
Study 21832184 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation (TMS) affecting ongoing motor commands
Number of subjects: 0
Study 21832184 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation (TMS) and internal feedback correction
Number of subjects: 0
Study 19210949 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief cognitive-behavioral therapy (CBT) delivered by mental health nurses trained over 10 days with ongoing supervision
Number of subjects: 422
Study 19210949 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 422
Study 19210949 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief cognitive-behavioral therapy (CBT)
Number of subjects: 422
Study 17118092 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing (tasteless and odorless substance for 15 min each hour)
Number of subjects: 14
Study 17118092 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 17118092 — intervention group
Group type: COMPARATOR
Intervention: Caffeine (200 mg)
Number of subjects: 14
Study 14975603 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-beta 1b treatment
Number of subjects: 29
Study 11598620 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle sympathetic nerve activity (MSA) in LSCS patients
Number of subjects: 12
Study 11598620 — intervention group
Group type: COMPARATOR
Intervention: Muscle sympathetic nerve activity (MSA) in normal subjects
Number of subjects: 12
Study 11598620 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory nerve conduction velocity (SNCV) in LSCS patients
Number of subjects: 12
Study 11598620 — intervention group
Group type: COMPARATOR
Intervention: Sensory nerve conduction velocity (SNCV) in normal subjects
Number of subjects: 12
Study 9881518 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium enriched yeast (4.8 mg containing 5 microg selenium daily via nasogastric drip during the first 14 postnatal days)
Number of subjects: 28
Study 9881518 — intervention group
Group type: COMPARATOR
Intervention: Nonsupplemented (reference group)
Number of subjects: 28
Study 7982105 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial Doppler ultrasonography after embolization with n-butyl cyanoacrylate
Number of subjects: 8
Study 7982105 — intervention group
Group type: COMPARATOR
Intervention: Nonfeeding arteries (ipsilateral and contralateral)
Number of subjects: 8
Study 2484663 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirbuterol 0.2 mg
Number of subjects: 24
Study 2484663 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirbuterol 0.4 mg
Number of subjects: 24
Study 2484663 — intervention group
Group type: COMPARATOR
Intervention: Metaproterenol 1.3 mg
Number of subjects: 24
Study 2484663 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 1242334 — intervention group
Group type: EXPERIMENTAL
Intervention: Instenon forte (hexobendine, etamivan, etofylline)
Number of subjects: 47
Study 31009823 — intervention group
Group type: EXPERIMENTAL
Intervention: REsTRAIN YOURSELF intervention (Six Core Strategies)
Number of subjects: 291
Study 31009823 — intervention group
Group type: COMPARATOR
Intervention: Control wards
Number of subjects: 291
Study 26658237 — intervention group
Group type: EXPERIMENTAL
Intervention: PPX/RT
Number of subjects: 63
Study 26658237 — intervention group
Group type: COMPARATOR
Intervention: TMZ/RT
Number of subjects: 63
Study 26954779 — intervention group
Group type: EXPERIMENTAL
Intervention: Cogmed working memory training (20 to 25 sessions of 45 minutes each at school)
Number of subjects: 452
Study 26954779 — intervention group
Group type: COMPARATOR
Intervention: Usual classroom teaching (control)
Number of subjects: 452
Study 25242501 — intervention group
Group type: EXPERIMENTAL
Intervention: Human voices
Number of subjects: 38
Study 25242501 — intervention group
Group type: COMPARATOR
Intervention: Baseline condition
Number of subjects: 38
Study 22293363 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 4,000 IU daily for 12 weeks
Number of subjects: 45
Study 22293363 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 20197426 — intervention group
Group type: EXPERIMENTAL
Intervention: Doubling the dose of ICS
Number of subjects: 0
Study 20197426 — intervention group
Group type: EXPERIMENTAL
Intervention: Adding a leukotriene-receptor antagonist to the ICS
Number of subjects: 0
Study 20197426 — intervention group
Group type: EXPERIMENTAL
Intervention: Adding a long-acting beta-agonist to the ICS
Number of subjects: 0
Study 19160885 — intervention group
Group type: EXPERIMENTAL
Intervention: HES 6%
Number of subjects: 44
Study 19160885 — intervention group
Group type: EXPERIMENTAL
Intervention: HES 10%
Number of subjects: 44
Study 19160885 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 44
Study 15788369 — intervention group
Group type: COMPARATOR
Intervention: CYP3A4 mRNA in Japanese livers (n = 24)
Number of subjects: 48
Study 15788369 — intervention group
Group type: COMPARATOR
Intervention: CYP3A5 mRNA in Japanese (n = 9)
Number of subjects: 48
Study 15788369 — intervention group
Group type: COMPARATOR
Intervention: CYP3A7 mRNA in Japanese (n = 24)
Number of subjects: 48
Study 12441749 — intervention group
Group type: EXPERIMENTAL
Intervention: HFOV plus iNO (n = 14)
Number of subjects: 108
Study 12441749 — intervention group
Group type: EXPERIMENTAL
Intervention: HFOV alone (n = 12)
Number of subjects: 108
Study 12441749 — intervention group
Group type: COMPARATOR
Intervention: CMV plus iNO (n = 35)
Number of subjects: 108
Study 12441749 — intervention group
Group type: COMPARATOR
Intervention: CMV alone (n = 38)
Number of subjects: 108
Study 10385832 — intervention group
Group type: EXPERIMENTAL
Intervention: Health promotion programme addressing barriers to implementing the New Zealand Playground Safety Standard; included information about hazards, an engineer's report, regular contact and encouragement, and assistance in obtaining funding.
Number of subjects: 24
Study 10385832 — intervention group
Group type: COMPARATOR
Intervention: Control group received only information about hazards in their playground.
Number of subjects: 24
Study 7728983 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 g of cooked Brussels sprouts per day
Number of subjects: 10
Study 7728983 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cruciferous vegetables)
Number of subjects: 10
Study 1823147 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral selenium plus copper associated with vitamin complex (tocopherol and retinol)
Number of subjects: 0
Study 1823147 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7364691 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer Tutoring Only
Number of subjects: 69
Study 7364691 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer Tutoring with Home Based Reinforcement
Number of subjects: 69
Study 7364691 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 69
Study 6860416 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily tobramycin dosing
Number of subjects: 52
Study 6860416 — intervention group
Group type: COMPARATOR
Intervention: Continuous infusion of tobramycin
Number of subjects: 52
Study 6860416 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily dosing of gentamicin, tobramycin, or netilmicin
Number of subjects: 52
Study 6860416 — intervention group
Group type: COMPARATOR
Intervention: Continuous tobramycin dosing
Number of subjects: 52
Study 31405899 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually tailored rituximab regimen
Number of subjects: 0
Study 31405899 — intervention group
Group type: COMPARATOR
Intervention: Fixed-schedule rituximab regimen
Number of subjects: 0
Study 30133461 — intervention group
Group type: EXPERIMENTAL
Intervention: Training intervention for shared decision-making
Number of subjects: 604
Study 30133461 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 604
Study 26243629 — intervention group
Group type: EXPERIMENTAL
Intervention: Floseal + harmonic scalpel (HS)
Number of subjects: 206
Study 26243629 — intervention group
Group type: COMPARATOR
Intervention: Floseal alone
Number of subjects: 206
Study 26243629 — intervention group
Group type: COMPARATOR
Intervention: HS alone
Number of subjects: 206
Study 26243629 — intervention group
Group type: COMPARATOR
Intervention: Standard total thyroidectomy
Number of subjects: 206
Study 24169960 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat fish oil (LFFO) diet
Number of subjects: 0
Study 24169960 — intervention group
Group type: COMPARATOR
Intervention: Western diet
Number of subjects: 0
Study 23062276 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 117
Study 23062276 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 117
Study 21131037 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid (4 mg infusion every 3-4 weeks)
Number of subjects: 1960
Study 21131037 — intervention group
Group type: COMPARATOR
Intervention: Clodronic acid (1600 mg oral daily)
Number of subjects: 1960
Study 17627194 — intervention group
Group type: EXPERIMENTAL
Intervention: Reiki touch therapy
Number of subjects: 0
Study 15760966 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH agonist (buserelin) 0.5 mg s.c.
Number of subjects: 122
Study 15760966 — intervention group
Group type: COMPARATOR
Intervention: hCG 10,000 IU
Number of subjects: 122
Study 12211672 — intervention group
Group type: EXPERIMENTAL
Intervention: Exeter femoral stem
Number of subjects: 0
Study 12211672 — intervention group
Group type: EXPERIMENTAL
Intervention: Elite Plus femoral stem
Number of subjects: 0
Study 10476343 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic cardiomyopathy (ACMP)
Number of subjects: 20
Study 10476343 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilated cardiomyopathy (DCMP)
Number of subjects: 20
Study 10476343 — intervention group
Group type: COMPARATOR
Intervention: Control group (accident death)
Number of subjects: 20
Study 8936778 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-arteritic anterior ischemic optic neuropathy group
Number of subjects: 37
Study 8936778 — intervention group
Group type: COMPARATOR
Intervention: Control group (sex and age matched)
Number of subjects: 37
Study 1934552 — intervention group
Group type: EXPERIMENTAL
Intervention: Ear-canal magnets treatment
Number of subjects: 50
Study 12760406 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobramycin 2.5 mg/kg/12 hr for a mean of 8 days
Number of subjects: 50
Study 12760406 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin 2.5 mg/kg/12 hr for a mean of 8 days
Number of subjects: 50
Study 12760406 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobramycin and Gentamicin
Number of subjects: 50
Study 30787665 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibration Foam Rolling (VFR)
Number of subjects: 38
Study 30787665 — intervention group
Group type: COMPARATOR
Intervention: Non-Vibration Foam Rolling (NVFR)
Number of subjects: 38
Study 28576354 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced air warming
Number of subjects: 132
Study 28576354 — intervention group
Group type: EXPERIMENTAL
Intervention: Conduction mattress warming
Number of subjects: 132
Study 28576354 — intervention group
Group type: COMPARATOR
Intervention: No active body warming
Number of subjects: 132
Study 28576354 — intervention group
Group type: COMPARATOR
Intervention: In-line intravenous fluid warming
Number of subjects: 132
Study 28576354 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal core temperature
Number of subjects: 132
Study 25708754 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined needle and snare unit
Number of subjects: 140
Study 25708754 — intervention group
Group type: COMPARATOR
Intervention: Spiral wire
Number of subjects: 140
Study 24299621 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint position error test
Number of subjects: 63
Study 24299621 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranio-cervical flexion test
Number of subjects: 63
Study 24299621 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck flexor muscle endurance test (supine)
Number of subjects: 63
Study 24299621 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck flexor muscle endurance test (45°-upright)
Number of subjects: 63
Study 24299621 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck extensor test
Number of subjects: 63
Study 21261988 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education intervention based on WHO's IMCI, consisting of eight monthly 30-minute sessions.
Number of subjects: 1855
Study 21261988 — intervention group
Group type: COMPARATOR
Intervention: Control group (no health education intervention).
Number of subjects: 1855
Study 19050692 — intervention group
Group type: EXPERIMENTAL
Intervention: Trans-rectal ultrasound (TRUS) for biopsy
Number of subjects: 0
Study 19050692 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging (MRI) or computed tomography (CT) for staging
Number of subjects: 0
Study 19050692 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomograms developed from PSA, Gleason score, and clinical grading
Number of subjects: 0
Study 17215658 — intervention group
Group type: EXPERIMENTAL
Intervention: HCTZ 50 mg/d
Number of subjects: 105
Study 17215658 — intervention group
Group type: COMPARATOR
Intervention: HCTZ 25 mg/d
Number of subjects: 105
Study 17215658 — intervention group
Group type: COMPARATOR
Intervention: OM 40 mg/d (monotherapy)
Number of subjects: 105
Study 15066064 — intervention group
Group type: EXPERIMENTAL
Intervention: Cane
Number of subjects: 42
Study 15066064 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle orthoses
Number of subjects: 42
Study 15066064 — intervention group
Group type: EXPERIMENTAL
Intervention: Touch of a vertical surface
Number of subjects: 42
Study 15066064 — intervention group
Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 42
Study 14713367 — intervention group
Group type: EXPERIMENTAL
Intervention: sho‐saiko‐to (2.5 g twice daily for five days)
Number of subjects: 26
Study 10084580 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant human GH (rhGH)
Number of subjects: 46
Study 10084580 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant human GH (rhGH) and oxandrolone (OX) in combination
Number of subjects: 46
Study 7552095 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous calcitriol
Number of subjects: 0
Study 7552095 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral calcitriol
Number of subjects: 0
Study 7552095 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily calcitriol administration
Number of subjects: 0
Study 7552095 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent calcitriol administration
Number of subjects: 0
Study 7552095 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiologic dosing of calcitriol
Number of subjects: 0
Study 7552095 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacologic dosing of calcitriol
Number of subjects: 0
Study 2048803 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking intervention program and prescription of an inhaled bronchodilator
Number of subjects: 5887
Study 2048803 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 5887
Study 7231338 — intervention group
Group type: EXPERIMENTAL
Intervention: Proglumid
Number of subjects: 70
Study 7231338 — intervention group
Group type: COMPARATOR
Intervention: Antacid
Number of subjects: 70
Study 30487565 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal sleep and meal conditions
Number of subjects: 5
Study 30487565 — intervention group
Group type: COMPARATOR
Intervention: Late sleep and meal conditions
Number of subjects: 5
Study 30487565 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal sleep and late meal conditions
Number of subjects: 5
Study 30487565 — intervention group
Group type: COMPARATOR
Intervention: Late sleep and normal meal conditions
Number of subjects: 5
Study 29309388 — intervention group
Group type: EXPERIMENTAL
Intervention: Variable load (30% 1RM constant load and 15% 1RM variable load; chains)
Number of subjects: 8
Study 29309388 — intervention group
Group type: COMPARATOR
Intervention: Constant load (no chains)
Number of subjects: 8
Study 26876144 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided bone regeneration (GBR) using acellular dermal matrix film combined with alveolar bone grafting using iliac crest bone grafts
Number of subjects: 60
Study 26876144 — intervention group
Group type: COMPARATOR
Intervention: Conventional alveolar bone grafting only (non‐GBR group)
Number of subjects: 60
Study 26876144 — intervention group
Group type: COMPARATOR
Intervention: Comparison between GBR and non-GBR groups
Number of subjects: 60
Study 24203933 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking relapse-prevention intervention
Number of subjects: 504
Study 22345878 — intervention group
Group type: EXPERIMENTAL
Intervention: Acamprosate 333 mg TDS
Number of subjects: 40
Study 22345878 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 20423242 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 microg estradiol vaginal tablets
Number of subjects: 58
Study 20423242 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 microg estradiol vaginal tablets
Number of subjects: 58
Study 20423242 — intervention group
Group type: COMPARATOR
Intervention: Comparison of 10 microg and 25 microg doses
Number of subjects: 58
Study 18675392 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive and supervised 21-week concurrent strength and endurance training
Number of subjects: 26
Study 15893183 — intervention group
Group type: EXPERIMENTAL
Intervention: Home Telemonitoring (HTM)
Number of subjects: 426
Study 15893183 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse Telephone Support (NTS)
Number of subjects: 426
Study 15893183 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 426
Study 12637127 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled formoterol dry powder 12 microg BID
Number of subjects: 780
Study 12637127 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide 40 microg QID
Number of subjects: 780
Study 12637127 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 780
Study 11036957 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraportal chemotherapy (5‐fluorouracil 500 mg/m2/day in continuous infusion for 7 days and mitomycin C 10 mg/m2 at day 7)
Number of subjects: 260